Literature DB >> 18350353

Growth rate of non-operated meningiomas.

L A Zeidman1, W J Ankenbrandt, Hongyan Du, N Paleologos, N A Vick.   

Abstract

INTRODUCTION: Meningiomas are dural-based brain tumors that are typically histologically benign. Some meningiomas grow slowly or seemingly not at all with planimetric measurement. Volumetric measurement may be more accurate because tumors may grow in different directions than the planimetric axes.
METHODS: Twenty-one patients (with 22 tumors) had serial MRI brain scans available for review. We reviewed the charts and measured tumor dimensions on the MRI scans. Relative growth rates were calculated for volume and maximum initial diameter using published formulas. Patient demographics, tumor location, and special radiologic characteristics (calcification, T2 hypointensity, dural tail, mass effect, and midline shift) were compared to the volumetric growth rate.
RESULTS: Patients included 17 females and 4 males; age at diagnosis 36 to 74 years (mean 61). Follow-up was 2.08 to 10.83 years (mean 3.64). Most tumors were located in the convexity (27.27 %), sphenoid wing (27.27 %), or cerebellopontine angle (13.04 %). Two meningiomas (9.09 %) demonstrated no growth. The mean relative volumetric growth rate was 5.82 %/year, and planimetric was 2.00 %/year (difference 3.82 %/year, p-value < 0.0001). Convexity location had near significant association with slower relative volumetric growth. There were no significant associations between other tumor locations, age, gender, or radiologic characteristics and volumetric growth.
CONCLUSIONS: The mean volumetric growth rate was significantly greater than the planimetric growth rate, suggesting that volumetric measurement conveys more information and is superior in assessing tumor growth. This information could have clinical value in determining the frequency of follow-up imaging and the urgency of surgical intervention.

Entities:  

Mesh:

Year:  2008        PMID: 18350353     DOI: 10.1007/s00415-008-0801-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

Review 1.  Natural history of conservatively treated meningiomas.

Authors:  Z Herscovici; Z Rappaport; J Sulkes; L Danaila; G Rubin
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

2.  Growth rate of incidental meningiomas.

Authors:  R P Firsching; A Fischer; R Peters; F Thun; N Klug
Journal:  J Neurosurg       Date:  1990-10       Impact factor: 5.115

3.  The ABCs of measuring intracerebral hemorrhage volumes.

Authors:  R U Kothari; T Brott; J P Broderick; W G Barsan; L R Sauerbeck; M Zuccarello; J Khoury
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

4.  Incidence and clinical features of asymptomatic meningiomas.

Authors:  J Kuratsu; M Kochi; Y Ushio
Journal:  J Neurosurg       Date:  2000-05       Impact factor: 5.115

5.  Meningiomas: the decision not to operate.

Authors:  J B Braunstein; N A Vick
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

6.  Growth of incidental meningiomas.

Authors:  Y Yoneoka; Y Fujii; R Tanaka
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

7.  Natural history of elderly patients with asymptomatic meningiomas.

Authors:  M Niiro; K Yatsushiro; K Nakamura; Y Kawahara; J Kuratsu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

8.  The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients.

Authors:  W C Olivero; J R Lister; P W Elwood
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

9.  The natural history of asymptomatic meningiomas in Olmsted County, Minnesota.

Authors:  R S Go; B V Taylor; D W Kimmel
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

10.  The natural history of incidental meningiomas.

Authors:  Makoto Nakamura; Florian Roser; Julia Michel; Cornelius Jacobs; Madjid Samii
Journal:  Neurosurgery       Date:  2003-07       Impact factor: 4.654

  10 in total
  21 in total

1.  MR imaging of brain volumes: evaluation of a fully automatic software.

Authors:  K Ambarki; A Wåhlin; R Birgander; A Eklund; J Malm
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

2.  Assessment of the treatment response of spinal meningiomas after radiosurgery focusing on serial MRI findings.

Authors:  Myung Eun Lee; Yoon Joon Hwang; Moon Jun Sohn; Byung Hoon Lee; Su Young Kim
Journal:  Jpn J Radiol       Date:  2015-07-14       Impact factor: 2.374

3.  A new metric for detecting change in slowly evolving brain tumors: validation in meningioma patients.

Authors:  Kilian M Pohl; Ender Konukoglu; Sebastian Novellas; Nicholas Ayache; Andriy Fedorov; Ion-Florin Talos; Alexandra Golby; William M Wells; Ron Kikinis; Peter M Black
Journal:  Neurosurgery       Date:  2011-03       Impact factor: 4.654

4.  An unusual growth of an intraventricular meningioma: a case report.

Authors:  Pierpaolo Lunardi; Carlo Conti; Rodolfo Corinaldesi; Giovanni Ghetti
Journal:  Neurol Sci       Date:  2011-01-14       Impact factor: 3.307

5.  Prediction of Histological Grade and Completeness of Resection of Intracranial Meningiomas: Role of Peritumoural Brain Edema.

Authors:  Kamalanathan Palaniandy; Mohammad Saffari Mohammad Haspani; Norzaini Rose Mohd Zain
Journal:  Malays J Med Sci       Date:  2017-06-30

6.  Comparison of ABC/2 estimation and a volumetric computerized method for measurement of meningiomas using magnetic resonance imaging.

Authors:  Charles F Opalak; Matthew Parry; Andrew K Rock; Adam P Sima; Matthew T Carr; Vyshak Chandra; Kathryn G Workman; Aravind Somasundaram; William C Broaddus
Journal:  J Neurooncol       Date:  2019-08-10       Impact factor: 4.130

Review 7.  Response assessment in neuro-oncology.

Authors:  Eudocia C Quant; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

Review 8.  Advances in meningioma therapy.

Authors:  Andrew D Norden; Jan Drappatz; Patrick Y Wen
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081

9.  Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.

Authors:  Yongli Ji; Cathryn Rankin; Steven Grunberg; Andy E Sherrod; Jamshid Ahmadi; Jeannette J Townsend; Lynn G Feun; Ruth K Fredericks; Christy A Russell; Fairooz F Kabbinavar; Keith J Stelzer; Anne Schott; Claire Verschraegen
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

Review 10.  Meningioma.

Authors:  Ali-Reza Fathi; Ulrich Roelcke
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.